Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH

被引:16
作者
Brookman-Amissah, N
Duchesnes, C
Williamson, MP
Wang, Q
Ahmed, A
Feneley, MR
Mackay, A
Freeman, A
Fenwick, K
Iravani, M
Weber, B
Ashworth, A
Masters, JR
机构
[1] UCL, Prostate Canc Res Ctr, Inst Urol, London W1W 7EJ, England
[2] Inst Canc Res, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England
[3] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
基金
英国医学研究理事会;
关键词
aCGH; prostate cancer cell lines; genetic changes;
D O I
10.1038/sj.pcan.4500826
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Copy number alterations in a matched pair of benign epithelial and prostate cancer cell lines derived from the same patient were assessed using array-based comparative genomic hybridisation (aCGH). The cancer cell line showed a gain of chromosome 7, deletion of chromosome 8, gains ( including high level) and losses on chromosome 11, loss of 18p and gain of 20q. Deletions on chromosome 8 were confirmed with microsatellite markers. The aCGH results were compared to gene expression data obtained using DNA microarrays and suggested the involvement of caspases and ICEBERG on 11q and E2F1 on chromosome 20q.
引用
收藏
页码:335 / 343
页数:9
相关论文
共 27 条
  • [1] High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22
    Arbieva, ZH
    Banerjee, K
    Kim, SY
    Edassery, SL
    Maniatis, VS
    Horrigan, SK
    Westbrook, CA
    [J]. GENOME RESEARCH, 2000, 10 (02) : 244 - 257
  • [2] Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer
    Asatiani, E
    Huang, WX
    Wang, A
    Ortner, ER
    Cavalli, LR
    Haddad, BR
    Gelmann, EP
    [J]. CANCER RESEARCH, 2005, 65 (04) : 1164 - 1173
  • [3] Bright RK, 1997, CANCER RES, V57, P995
  • [4] Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays
    Clark, J
    Edwards, S
    Feber, A
    Flohr, P
    John, M
    Giddings, I
    Crossland, S
    Stratton, MR
    Wooster, R
    Campbell, C
    Cooper, CS
    [J]. ONCOGENE, 2003, 22 (08) : 1247 - 1252
  • [5] Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells
    Davis, JN
    McCabe, MT
    Hayward, SW
    Park, JM
    Day, ML
    [J]. CANCER RESEARCH, 2005, 65 (09) : 3633 - 3642
  • [6] Chromosomal deletions and tumor suppressor genes in prostate cancer
    Dong, JT
    [J]. CANCER AND METASTASIS REVIEWS, 2001, 20 (3-4) : 173 - 193
  • [7] El Gedaily A, 2001, PROSTATE, V46, P184
  • [8] A NOVEL HUMAN PROTEASE SIMILAR TO THE INTERLEUKIN-1-BETA CONVERTING-ENZYME INDUCES APOPTOSIS IN TRANSFECTED CELLS
    FAUCHEU, C
    DIU, A
    CHAN, AWE
    BLANCHET, AM
    MIOSSEC, C
    HERVE, F
    COLLARDDUTILLEUL, V
    GU, Y
    ALDAPE, RA
    LIPPKE, JA
    ROCHER, C
    SU, MSS
    LIVINGSTON, DJ
    HERCEND, T
    LALANNE, JL
    [J]. EMBO JOURNAL, 1995, 14 (09) : 1914 - 1922
  • [9] Cyclooxygenase-2 promotes prostate cancer progression
    Fujita, H
    Koshida, K
    Keller, ET
    Takahashi, Y
    Yoshimito, T
    Namiki, M
    Mizokami, A
    [J]. PROSTATE, 2002, 53 (03) : 232 - 240
  • [10] Greshock J, 2004, GENOME RES, V14, P179